Five Prime trial investigator pleads guilty to $134K insider trading scheme, faces up to 25 years in prison

A trial investigator involved with a Phase II study run by the biotech Five Prime Therapeutics has pled guilty to an insider trading probe. …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Five Prime tri­al in­ves­ti­ga­tor pleads guilty to $134K in­sid­er trad­ing scheme, faces up to 25 years in prison